PRN-371
PRN-371 is a potent and selective JAK3 inhibitor. PRN371 effectively suppresses natural killer/T-cell lymphoma cell proliferation and induces apoptosis through abrogation of the JAK3-STAT signaling. PRN-371 exhibits antitumor activity and can be used for the research of cancer, such as hematological malignancies[1].
Product Specifications
CAS Number
[1610974-55-4]
UNSPSC
12352005
Target
Apoptosis; JAK
Related Pathways
Apoptosis; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Field of Research
Cancer
Smiles
O=C(C1=CNC2=NC=C(C3=CC=CC(NC(C=C)=O)=C3)N=C21)NC(C)(C)C
Molecular Formula
C20H21N5O2
Molecular Weight
363.41
References & Citations
[1]Nairismägi M-, et al. Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma. Leukemia. 2018 May;32 (5) :1147-1156.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
JAK3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
